中手游(00302.HK)肖健:「仙劍奇俠傳:世界」明年第三季測試 2023年正式上線
中手游(00302.HK)董事長兼CEO肖健於投資者交流會上透露,將在國風文化熱潮下將「仙劍元宇宙」打造成首個國風文化元宇宙,開發已近兩年時間的仙劍元宇宙遊戲《仙劍奇俠傳:世界》,將成為國內首個具備開放世界元素的國風文化元宇宙遊戲。
該遊戲支持多平台,覆蓋PC、主機、移動端以及VR和雲遊戲等所有主流硬件設備及體驗模式,預計於2022年第三季測試,2023年內正式上線。
肖健表示,仙劍元宇宙將按照數字孿生、虛擬原生、虛實融生三步規劃,從而實現虛擬世界與現實世界界限模糊、互相交融的目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.